Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Author Correction: Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA.
Loomba, S; De Figueiredo, A; Piatek, SJ; De Graaf, K; LARSON, HJ;
2021
Nature human behaviour, (2021).5 3 10.1038/s41562-021-01088-7.
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
Leach, AJ; MULHOLLAND, EK; Santosham, M; Torzillo, PJ; McIntyre, P; Smith-Vaughan, H; Wilson, N; Arrowsmith, B; Beissbarth, J; Chatfield, MD; Oguoma, VM; Morris, PS;
2021
BMC pediatrics, (2021).21 1 10.1186/s12887-021-02552-z.
Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members.
Hotez, P; Batista, C; Ergonul, O; Figueroa, JP; Gilbert, S; Gursel, M; Hassanain, M; Kang, G; Kim, JH; Lall, B; LARSON, H; Naniche, D; Sheahan, T; Shoham, S; WILDER-SMITH, A; Strub-Wourgaft, N; Yadav, P; Bottazzi, ME;
2021
EClinicalMedicine, (2021).33, 10.1016/j.eclinm.2021.100780.
Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.
Driciru, E; Koopman, JP R; COSE, S; Siddiqui, AA; Yazdanbakhsh, M; ELLIOTT, AM; Roestenberg, M;
2021
Frontiers in immunology, (2021).12, 10.3389/fimmu.2021.635985.
Framework for Characterizing Longitudinal Antibody Response in Children After Plasmodium falciparum Infection.
Rogier, E; Nace, D; Dimbu, PR; Wakeman, B; Pohl, J; Beeson, JG; DRAKELEY, C; TETTEH, K; Plucinski, M;
2021
Frontiers in immunology, (2021).12, 10.3389/fimmu.2021.617951.
Human Papillomavirus Vaccination After COVID-19.
Toh, ZQ; Russell, FM; Garland, SM; MULHOLLAND, EK; Patton, G; Licciardi, PV;
2021
JNCI cancer spectrum, (2021).5 2 10.1093/jncics/pkab011.
Access to Vaccination Information and Confidence/Hesitancy Towards Childhood Vaccination: A Cross-Sectional Survey in China.
Du, F; CHANTLER, T; Francis, MR; Sun, FY; Zhang, X; Han, K; Rodewald, L; Yu, H; Tu, S; LARSON, H; Hou, Z;
2021
Vaccines, (2021).9 3 10.3390/vaccines9030201.
Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease.
Mutavhatsindi, H; Van der Spuy, GD; Malherbe, ST; SUTHERLAND, JS; Geluk, A; Mayanja-Kizza, H; CRAMPIN, AC; Kassa, D; Howe, R; Mihret, A; Sheehama, JA; Nepolo, E; Günther, G; DOCKRELL, HM; Corstjens, PL A M; Stanley, K; Walzl, G; Chegou, NN; AE-TBC ScreenTB Consortia,;
2021
Frontiers in immunology, (2021).12, 10.3389/fimmu.2021.607827.
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
WEERASURIYA, CK; Harris, RC; MCQUAID, CF; BOZZANI, F; Ruan, Y; Li, R; Li, T; Rade, K; Rao, R; Ginsberg, AM; Gomez, GB; WHITE, RG;
2021
BMC Medicine, (2021).19 1 10.1186/s12916-021-01932-7.
COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness.
PEARSON, C; BOZZANI, F; Procter, S; DAVIES, N; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; EGGO, R; VASSALL, A; JIT, M; CHiL COVID-19 Working Group,; CMMID COVID-19 Working Group,;
2021
(2021). 10.1101/2021.02.24.21252338.